Genetics in scleroderma;Genética de la esclerodermia

Reumatologia Clinica

Volumn 6, Issue SUPPL. 2, 2010, Pages 12-15

  Bossini Castillo, Lara ^a   Martín, José Ezequiel ^a   Díaz Gallo, Lina Marcela ^a   Rueda, Blanca ^a,b   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Genome wide association studies ; Genetics; Systemic sclerosis

Indexed keywords

HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; STAT4 PROTEIN; HLA DRB1 ANTIGEN;

ALLELE; ARTICLE; BANK1 GENE; BLK GENE; DATA ANALYSIS; DISEASE PREDISPOSITION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HLA SYSTEM; HUMAN; PATHOGENESIS; PHENOTYPE; REGULATOR GENE; SCLERODERMA; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH17 CELL; AUTOIMMUNITY; ENDOTHELIAL DYSFUNCTION; FIBROSIS; GENETICS; REVIEW; SYSTEMIC SCLEROSIS;

EID: 77957253365     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2010.04.005     Document Type: Article

References (33)

1. Jiménez S.A., Derk C.T. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004, 140:37-50.
2. Agarwal S.K., Tan F.K., Arnett F.C. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2010, 32:127-136.
3. Assassi S., Arnett F.C., Reveille J.D., Gourh P., Mayes M.D. Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum 2007, 56:2031-2037.
4. Arnett FC, Gourh P, Shete S, Ahn CW, Honey R, Agarwal SK, et al. Major Histocompatibility Complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010;69:822-7.
5. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009, 10:43-55.
6. Altshuler D., Daly M.J., Lander E.S. Genetic mapping in human disease. Science 2008, 322:881-888.
7. Kruglyak L. The road to genome-wide association studies. Nat Rev Genet 2008, 9:314-318.
8. Gregersen P.K., Olsson L.M. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 2009, 27:363-391.
9. Peng S.L. Transcription factors in autoimmune diseases. Front Biosci 2008, 13:4218-4240.
10. Deleuran B., Abraham D.J. Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat Clin Pract Rheumatol 2007, 3:682-683.
11. Gu Y.S., Kong J., Cheema G.S., Keen C.L., Wick G., Gershwin M.E. The immunobiology of systemic sclerosis. Semin Arthritis Rheum 2008, 38:132-160.
12. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178:4901-4907.
13. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
14. Orozco G., Alizadeh B.Z., Delgado-Vega A.M., González-Gay M.A., Balsa A., Pascual-Salcedo D., et al. Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. Arthritis Rheum 2008, 58:1974-1980.
15. Abelson A.K., Delgado-Vega A.M., Kozyrev S.V., Sánchez E., Velázquez-Cruz R., Eriksson N., et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 2009, 68:1746-1753.
16. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
17. Martinez A., Varade J., Márquez A., Cenit M.C., Espino L., Perdigones N., et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum 2008, 58:2598-2602.
18. Rueda B., Broen J., Simeon C., Hesselstrand R., Díaz B., Suárez H., et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet 2009, 18:2071-2077.
19. Dieude P., Guedj M., Wipff J., Ruiz B., Hachulla E., Diot E., et al. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 2009, 60:2472-2479.
20. Tsuchiya N., Kawasaki A., Hasegawa M., Fujimoto M., Takehara K., Kawaguchi Y., et al. Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann Rheum Dis 2009, 68:1375-1376.
21. Honda K., Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006, 6:644-658.
22. Dieude P., Guedj M., Wipff J., Avouac J., Fajardy I., Diot E., et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 2009, 60:225-233.
23. Ito I., Kawaguchi Y., Kawasaki A., Hasegawa M., Ohashi J., Hikami K., et al. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis Rheum 2009, 60:1845-1850.
24. Stanford SM, Mustelin TM, Bottini N. Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases. Semin Immunopathol. 2010;32:127-36.
25. Suárez-Gestal M., Calaza M., Endreffy E., Pullmann R., Ordi-Ros J., Domenico Sebastiani G., et al. Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 2009, 11:R69.
26. Ito I., Kawasaki A., Ito S., Hayashi T., Goto D., Matsumoto I., et al. Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population. Arthritis Rheum 2009, 60:553-558.
27. Gourh P, Agarwal SK, Martin E, Divecha D, Rueda B, Bunting H, et al. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun. 2010;34:155-62.
28. Ito I, Kawaguchi Y, Kawasaki A, Hasegawa M, Ohashi J, Kawamoto M, et al. Association of the FAM167A-BLK region with systemic sclerosis. Arthritis Rheum. 2010;62: 890-5.
29. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.V., Sanchez E., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:211-216.
30. Orozco G., Abelson A.K., González-Gay M.A., Balsa A., Pascual-Salcedo D., García A., et al. Study of functional variants of the BANK1 gene in rheumatoid arthritis. Arthritis Rheum 2009, 60:372-379.
31. Rueda B, Gourh P, Broen J, Agarwal SK, Simeon C, Ortego-Centeno N, et al. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann Rheum Dis. 2010;69: 700-5.
32. Dieude P., Wipff J., Guedj M., Ruiz B., Melchers I., Hachulla E., et al. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum 2009, 60:3447-3454.
33. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010;42:426-9.